Regeneron Pharmaceuticals holds Coefficient Of Variation of 227.54, Semi Deviation of 0.4855 and Risk Adjusted Performance of 0.2714. Compared with Fundamental Indicators, Macroaxis technical analysis interface allows you to check existing technical drivers of Regeneron Pharmaceuticals as well as the relationship between them. In other words you can use this information to find out if the company will indeed mirror its model of past market data or the prices will eventually revert. We found nineteen technical drivers for Regeneron Pharmaceuticals which can be compared to its competitors. Please check Regeneron PharmaceuticalsDownside Deviation, Jensen Alpha as well as the relationship between Jensen Alpha and Downside Variance to decide if Regeneron Pharmaceuticals is priced some-what accurately providing market reflects its current price of 364.75 per share. Given that Regeneron Pharmaceuticals has Jensen Alpha of 0.5811, we recommend you check out Regeneron Pharmaceuticals recent market performance to make sure the company can sustain itself at future point.
The output start index for this execution was fourteen with a total number of output elements of three. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Regeneron Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.
Regeneron Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Regeneron Pharmaceuticals. You can use it to identify possible trend reversals for Regeneron Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Regeneron Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.
Regeneron Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Regeneron Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 2.77 % which means Regeneron Pharmaceuticals will continue generating value for investors. It has 34 observation points and a regression sum of squares at 6267.63, which is the sum of squared deviations for the predicted Regeneron Pharmaceuticals price change compared to its average price change.
Diversify with Regeneron Pharmaceuticals
Build Optimal Portfolios
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Regeneron Pharmaceuticals to your portfolio